Pharmacological effects of berberine and its derivatives: a patent update
- PMID: 26610159
- DOI: 10.1517/13543776.2016.1118060
Pharmacological effects of berberine and its derivatives: a patent update
Abstract
Introduction: A number of plant-derived agents are used in many therapeutic areas. Berberine, an important protoberberine alkaloid, is present in a number of medicinal plants that have been widely used in traditional Chinese medicine for hundreds of years. Modern research has shown that berberine and its derivatives display several pharmacological effects through various mechanisms.
Areas covered: This review discusses recent and mostly Chinese patents that report the synthesis of berberine, berberine derivatives and berberine salts, and methods of preparation for formulations (traditional Chinese medicine) containing herbal components rich in berberine, along with their applications. The review covers several therapeutic effects of berberine, its derivatives and pharmaceutical formulations against cancer, obesity, diabetes, inflammation, atherosclerosis, Alzheimer's disease, rheumatoid arthritis and cardiovascular diseases. In addition, the mechanisms underlying the pharmacological effects are discussed.
Expert opinion: Modification of the functional groups of berberine has a significant effect on the pharmacological activity. However, studies on altering the atoms and size of the berberine skeleton are rare. Thus, it may be beneficial to initiate a drug development program focused on inserting heterocyclic rings of different sizes into berberine. Furthermore, structural modification to improve the safety, efficacy and selectivity is necessary to promote the use of berberine-based drugs in clinical settings.
Keywords: Alzheimer’s disease; berberine; cancer; diabetes; inflammation; obesity.
Similar articles
-
Berberine and its derivatives: a patent review (2009 - 2012).Expert Opin Ther Pat. 2013 Feb;23(2):215-31. doi: 10.1517/13543776.2013.746314. Epub 2012 Dec 12. Expert Opin Ther Pat. 2013. PMID: 23231038 Review.
-
Berberine Derivatives with Different Pharmacological Activities via Structural Modifications.Mini Rev Med Chem. 2018;18(17):1424-1441. doi: 10.2174/1389557517666170321103139. Mini Rev Med Chem. 2018. PMID: 28325147 Review.
-
Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations.J Ethnopharmacol. 2009 Oct 29;126(1):5-17. doi: 10.1016/j.jep.2009.08.009. Epub 2009 Aug 15. J Ethnopharmacol. 2009. PMID: 19686830 Review.
-
An insight into the medicinal attributes of berberine derivatives: A review.Bioorg Med Chem. 2021 May 15;38:116143. doi: 10.1016/j.bmc.2021.116143. Epub 2021 Apr 2. Bioorg Med Chem. 2021. PMID: 33848698 Review.
-
Berberine for bone regeneration: Therapeutic potential and molecular mechanisms.J Ethnopharmacol. 2021 Sep 15;277:114249. doi: 10.1016/j.jep.2021.114249. Epub 2021 May 29. J Ethnopharmacol. 2021. PMID: 34058315 Review.
Cited by
-
Synergic Effects of Berberine and Curcumin on Improving Cognitive Function in an Alzheimer's Disease Mouse Model.Neurochem Res. 2020 May;45(5):1130-1141. doi: 10.1007/s11064-020-02992-6. Epub 2020 Feb 21. Neurochem Res. 2020. PMID: 32080784
-
Berberrubine protects against cisplatin-induced ototoxicity by promoting folate biosynthesis.Front Pharmacol. 2025 Jan 9;15:1496917. doi: 10.3389/fphar.2024.1496917. eCollection 2024. Front Pharmacol. 2025. PMID: 39850559 Free PMC article.
-
Berberine Exerts Neuroprotective Effects in Alzheimer's Disease by Switching Microglia M1/M2 Polarization Through PI3K-AKT Signaling.Physiol Res. 2025 Mar 24;74(1):129-140. doi: 10.33549/physiolres.935410. Physiol Res. 2025. PMID: 40126149 Free PMC article.
-
Retracted Article: Berberine alleviates amyloid beta-induced injury in Alzheimer's disease by miR-107/ZNF217.RSC Adv. 2019 Aug 13;9(43):25232-25239. doi: 10.1039/c9ra04500g. eCollection 2019 Aug 8. RSC Adv. 2019. PMID: 35528669 Free PMC article.
-
Berberine-Loaded Liposomes for the Treatment of Leishmania infantum-Infected BALB/c Mice.Pharmaceutics. 2020 Sep 9;12(9):858. doi: 10.3390/pharmaceutics12090858. Pharmaceutics. 2020. PMID: 32916948 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources